We conclude that the absence of p-tau217 immunopositivity in GVBs in tauopathy brain is not due to incompatibility of the antibody with GVBs in human brain, but most likely caused by GVB target distraction of the antibody by the abundant tau pathology, which is not present in PD. The gene discussed is MAPT; the disease is Parkinson disease.